Penicillin levels in blood and CSF achieved by treatment of syphilis

Insights

Penicillin G procaine with aluminum monostearate did not achieve treponemicidal levels in CSF. Combining penicillin G with probenecid successfully reached therapeutic penicillin concentrations in cerebrospinal fluid for syphilis treatment.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Neurology

Background:

  • Penicillin is the primary treatment for neurosyphilis.
  • Achieving adequate penicillin concentrations in cerebrospinal fluid (CSF) is crucial for effective treatment.
  • Penicillin G procaine with aluminum monostearate (PAM) has been used to prolong penicillin release.

Purpose of the Study:

  • To evaluate if intramuscular injections of penicillin G procaine with aluminum monostearate can achieve treponemicidal penicillin levels in CSF.
  • To assess the efficacy of probenecid in combination with penicillin G or penicillin G procaine for achieving therapeutic CSF penicillin levels.

Main Methods:

  • Patients received varying doses of intramuscular penicillin G procaine with aluminum monostearate.
  • In other patient groups, oral probenecid was administered concurrently with intramuscular penicillin G or penicillin G procaine.
  • CSF penicillin levels were measured to determine treponemicidal concentrations.

Main Results:

  • Intramuscular injections of 600,000 IU penicillin G procaine with PAM did not yield treponemicidal CSF penicillin levels.
  • Concurrent administration of probenecid with penicillin G or penicillin G procaine successfully achieved treponemicidal CSF penicillin levels in a significant proportion of patients.
  • Higher doses of penicillin G procaine, when combined with probenecid, increased the likelihood of achieving therapeutic CSF concentrations.

Conclusions:

  • Penicillin G procaine with aluminum monostearate alone is insufficient for achieving treponemicidal penicillin levels in CSF.
  • Probenecid significantly enhances CSF penetration of penicillin, making it a valuable adjunct for treating neurosyphilis.
  • Combination therapy with probenecid and penicillin G or penicillin G procaine is effective in reaching therapeutic CSF penicillin concentrations.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...